Neurotrophins are a group of proteins that play a critical role in the health and function of our nervous system. They are ...
Peptide Therapeutics MarketThe global peptide therapeutics market is on a strong growth trajectory, with sales projected to ...
The global leukemia therapeutics treatment market has seen considerable growth, progressing from USD 14,504.8 million in 2022 to USD 15,246.7 million in 2023. With a projected compound annual growth ...
The veterinary auto-immune therapeutics market is projected to grow at a 5.3% CAGR, reaching $71.7 billion by 2033.
Exicure, Inc. (Nasdaq: XCUR, “Exicure”, “the Company”), has announced the signing of a Memorandum of Understanding (MOU) with GPCR Therapeutics, Inc. (“GPCR ...
Viking Therapeutics, Inc. (VKTX) closed the latest trading day at $42.68, indicating a +0.78% change from the previous session's end. This move outpaced the S&P 500's daily loss of 0.04%.
Viridian Therapeutics, Inc. has a fifty-two week low of $11.40 and a fifty-two week high of $27.20. The firm has a market cap of $1.53 billion, a P/E ratio of -4.48 and a beta of 1.04. The company ...
Stevie is a 1-year-old mixed breed with a social and playful demeanor. She will be your best friend the second you meet her! She loves to talk and never stops wagging her tail. Stevie lived with ...
Elinor Lawless, known for her role as Stevie Nash in Casualty, leads a life just as dramatic as her on-screen character. Since joining the show in 2021, Elinor has been open about her personal ...
Merck just closed a deal to develop a weight-loss drug. The market appears to think Viking Therapeutics is threatened by that data. There's little reason to write off Viking here. First ...
Stevie Nicks, for example, only knocked her drug addiction on the head when her doctor advised her that she wasn’t far off suffering a brain haemorrhage due to substance abuse. She already had a ...
A turbulent month at Applied Therapeutics is being capped off with the departure of CEO and chair Shoshana Shendelman, Ph.D., mere days after she and the company were named in a proposed class ...